96 related articles for article (PubMed ID: 22338520)
1. [Pelvic pain in the athlete: not always that simple...].
Ziltener JL; Leal S
Rev Med Suisse; 2012 Jan; 8(325):210, 212. PubMed ID: 22338520
[No Abstract] [Full Text] [Related]
2. Osteoporosis drugs not linked to atrial fibrillation.
Harv Heart Lett; 2009 Apr; 19(8):6. PubMed ID: 19685565
[No Abstract] [Full Text] [Related]
3. Controversies in osteoporosis management: concerns about bisphosphonates and when are "drug holidays" required?
McClung M
Clin Obstet Gynecol; 2013 Dec; 56(4):743-8. PubMed ID: 24177063
[TBL] [Abstract][Full Text] [Related]
4. Atypical femoral fractures and their relation to bisphosphonate use.
Tripto-Shkolnik L
Isr Med Assoc J; 2013 Aug; 15(8):447-50. PubMed ID: 24079069
[No Abstract] [Full Text] [Related]
5. Atypical diaphyseal femur fractures in patients with prolonged administration of bisphosphonate medication for osteoporosis.
Horning JA; Czajka J; Uhl RL
Orthopedics; 2010 Dec; 33(12):902. PubMed ID: 21117565
[No Abstract] [Full Text] [Related]
6. Bisphosphonates for osteoporosis: benefits and risks.
Bollerslev J; Harris ST; Leder BZ
J Clin Endocrinol Metab; 2011 Sep; 96(9):27A, 28A. PubMed ID: 21896893
[No Abstract] [Full Text] [Related]
7. Can the bisphosphonate I'm taking for osteoporosis actually cause a bone fracture?
Johns Hopkins Med Lett Health After 50; 2011 Oct; 23(8):7. PubMed ID: 22059260
[No Abstract] [Full Text] [Related]
8. Should bisphosphonates be used in premenopausal women?
Cohen A
Maturitas; 2010 May; 66(1):3-4. PubMed ID: 20356692
[No Abstract] [Full Text] [Related]
9. Images in emergency medicine. Elderly woman with right thigh pain. Atypical femur fracture.
Pulia MS; Hansen B
Ann Emerg Med; 2014 Mar; 63(3):370, 374. PubMed ID: 24528947
[No Abstract] [Full Text] [Related]
10. What is the optimal duration of bisphosphonate therapy?
Ott SM
Cleve Clin J Med; 2011 Sep; 78(9):619-30. PubMed ID: 21885695
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic holidays in osteoporosis: Long-term strategy of treatment with bisphosphonates].
Moro Álvarez MJ; Neyro JL; Castañeda S
Med Clin (Barc); 2016 Jan; 146(1):24-9. PubMed ID: 26048545
[TBL] [Abstract][Full Text] [Related]
12. [When should bisphosphonate treatment be discontinued?].
Eriksen EF; Halse J
Tidsskr Nor Laegeforen; 2012 Aug; 132(14):1630-2. PubMed ID: 22875131
[No Abstract] [Full Text] [Related]
13. Treating osteoporosis.
Smith G; Stassen L; Flint S
Ir Med J; 2009 Mar; 102(3):88; author reply 89. PubMed ID: 19489199
[No Abstract] [Full Text] [Related]
14. Bisphosphonates for the prevention and treatment of osteoporosis.
Maraka S; Kennel KA
BMJ; 2015 Sep; 351():h3783. PubMed ID: 26333528
[TBL] [Abstract][Full Text] [Related]
15. Diabetes and the risk of osteonecrosis of the jaw.
Favus MJ
J Clin Endocrinol Metab; 2007 Mar; 92(3):817-8. PubMed ID: 17341579
[No Abstract] [Full Text] [Related]
16. Bisphosphonates. A cornerstone of osteoporosis treatment.
Mayo Clin Womens Healthsource; 2007 May; 11(5):1-2. PubMed ID: 17476171
[No Abstract] [Full Text] [Related]
17. Treating osteoporosis: do bisphosphonates really increase the risk of osteonecrosis of the jaw?
Thompson E; Sheehy C; Barry M; Carey J
Ir Med J; 2008 Jun; 101(6):166-7. PubMed ID: 18700507
[No Abstract] [Full Text] [Related]
18. [New bone density conservation agents for osteoporosis under research and development: Zoledronate].
Wada S; Fukawa T; Kamiya S
Nihon Rinsho; 2007 Nov; 65 Suppl 9():421-5. PubMed ID: 18161143
[No Abstract] [Full Text] [Related]
19. Bisphosphonates in the treatment of osteoporosis.
Diab DL; Watts NB
Endocrinol Metab Clin North Am; 2012 Sep; 41(3):487-506. PubMed ID: 22877426
[TBL] [Abstract][Full Text] [Related]
20. [Bisphosphonate].
Hagino H
Nihon Rinsho; 2011 Jul; 69(7):1253-7. PubMed ID: 21774367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
